BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37973660)

  • 21. Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity.
    Kim CH; Kim YD; Choi EK; Kim HR; Na BR; Im SH; Jun CD
    J Biol Chem; 2016 Mar; 291(12):6169-81. PubMed ID: 26797131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.
    Tang J; Xie Y; Huang J; Zhang L; Jiang W; Li Z; Bian J
    Bioorg Med Chem; 2022 Sep; 70():116921. PubMed ID: 35863237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40.
    Patel NA; Kaneko S; Apostolatos HS; Bae SS; Watson JE; Davidowitz K; Chappell DS; Birnbaum MJ; Cheng JQ; Cooper DR
    J Biol Chem; 2005 Apr; 280(14):14302-9. PubMed ID: 15684423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells.
    Hu ZY; Wang XY; Guo WB; Xie LY; Huang YQ; Liu YP; Xiao LW; Li SN; Zhu HF; Li ZG; Kan H
    Oncotarget; 2016 Mar; 7(10):11733-43. PubMed ID: 26887056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobilization of a splicing factor through a nuclear kinase-kinase complex.
    Aubol BE; Keshwani MM; Fattet L; Adams JA
    Biochem J; 2018 Feb; 475(3):677-690. PubMed ID: 29335301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target.
    Ponce de León C; Lorite P; López-Casado MÁ; Barro F; Palomeque T; Torres MI
    Front Immunol; 2021; 12():678400. PubMed ID: 34220824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Serine-Arginine (SR) Protein Phosphorylation Changes Pre-mRNA Splicing in Hypoxia.
    Jakubauskiene E; Vilys L; Makino Y; Poellinger L; Kanopka A
    J Biol Chem; 2015 Jul; 290(29):18079-18089. PubMed ID: 26023237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conserved proline-directed phosphorylation regulates SR protein conformation and splicing function.
    Keshwani MM; Aubol BE; Fattet L; Ma CT; Qiu J; Jennings PA; Fu XD; Adams JA
    Biochem J; 2015 Mar; 466(2):311-22. PubMed ID: 25529026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer.
    Wang C; Weng M; Xia S; Zhang M; Chen C; Tang J; Huang D; Yu H; Sun W; Zhang H; Lai M
    Cancer Sci; 2021 Jan; 112(1):178-193. PubMed ID: 33058325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
    Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
    PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
    Solorzano-Ibarra F; Alejandre-Gonzalez AG; Ortiz-Lazareno PC; Bastidas-Ramirez BE; Zepeda-Moreno A; Tellez-Bañuelos MC; Banu N; Carrillo-Garibaldi OJ; Chavira-Alvarado A; Bueno-Topete MR; Del Toro-Arreola S; Haramati J
    Clin Exp Immunol; 2021 Apr; 204(1):78-95. PubMed ID: 33306195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.
    Fromm G; de Silva S; Johannes K; Patel A; Hornblower JC; Schreiber TH
    J Immunother Cancer; 2018 Dec; 6(1):149. PubMed ID: 30563566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing.
    Li D; Yu W; Lai M
    Drug Discov Today; 2023 Sep; 28(9):103691. PubMed ID: 37385370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression.
    Chandra A; Ananda H; Singh N; Qamar I
    Aging (Albany NY); 2020 Dec; 13(1):163-180. PubMed ID: 33291073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine.
    Zhou J; Cheung AK; Liu H; Tan Z; Tang X; Kang Y; Du Y; Wang H; Liu L; Chen Z
    Mol Ther; 2013 Jul; 21(7):1445-55. PubMed ID: 23587922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic activity of anti-mucin 1 chimeric antigen receptor T cells expressing PD-1-CD28 switch receptor against cholangiocarcinoma cells.
    Supimon K; Sangsuwannukul T; Sujjitjoon J; Chieochansin T; Junking M; Yenchitsomanus PT
    Cytotherapy; 2023 Feb; 25(2):148-161. PubMed ID: 36396553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directional Phosphorylation and Nuclear Transport of the Splicing Factor SRSF1 Is Regulated by an RNA Recognition Motif.
    Serrano P; Aubol BE; Keshwani MM; Forli S; Ma CT; Dutta SK; Geralt M; Wüthrich K; Adams JA
    J Mol Biol; 2016 Jun; 428(11):2430-2445. PubMed ID: 27091468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM; Freeman GJ; McDermott DF
    Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.